Imatinib (inhaled formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imatinib (inhaled formulation), covering 2024-10-10 to 2024-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) [Phase 3]